AstraZeneca’s chief executive Pascal Soriot said the company took the detention of its China president “very seriously”, as the drugmaker raised its guidance for the second time in less than four months on the back of strong sales of cancer medicines.
“We take the matters in China very seriously,” Soriot said as the company reported third-quarter results on Tuesday. “If requested we will fully co-operate with the authorities.”
Soriot’s comments come after the FTSE 100 group confirmed last week that the head of its China business, Leon Wang, had been detained, and that two former and two current executives were under investigation in China over allegations of illegally importing oncology medicines.
您已閱讀26%（704字），剩余74%（2018字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。